Literature DB >> 18162058

Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up.

Kristina Teär Fahnehjelm1, Gerd Holmström, Liu Ying, Charlotte Bieneck Haglind, Anna Nordenström, Maria Halldin, Jan Alm, Antal Nemeth, Ulrika von Döbeln.   

Abstract

PURPOSE: To present long-term ocular complications and electroretinographic (ERG) findings in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency - a life-threatening metabolic disease - and the relation to age at diagnosis, treatment and other clinical parameters.
METHODS: Ten children with LCHAD deficiency underwent repeated ophthalmological evaluations including ERG.
RESULTS: All 10 children developed chorioretinal pathology. Regardless of age at diagnosis, initiation of treatment and age at examination, inter-individual differences were present. Profound chorioretinal atrophy, severe visual impairment and progressive myopia had developed in two teenagers. Milder chorioretinopathy with or without subnormal visual acuity was present in all other children. ERG was pathological in seven children. The chorioretinopathy often started in the peripapillary or perimacular areas. In one patient, unilateral visual impairment was associated with fibrosis.
CONCLUSION: Early diagnosis and adequate therapy might delay but not prevent the progression of retinal complications. Late diagnosis with severe symptoms at diagnosis, neonatal hypoglycaemia and frequent decompensations may increase the progression rate of the chorioretinopathy. LCHAD deficiency, a potentially lethal disease, is sometimes difficult to diagnose. Unusual chorioretinal findings should alert the ophthalmologist to the long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, especially if there is a history of neonatal hypoglycaemia or failure to thrive.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162058     DOI: 10.1111/j.1600-0420.2007.01121.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  14 in total

1.  Growth in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.

Authors:  C Bieneck Haglind; M Halldin Stenlid; S Ask; J Alm; A Nemeth; Uv Döbeln; A Nordenström
Journal:  JIMD Rep       Date:  2012-07-06

2.  [Ocular signs of a mitochondrial trifunctional protein defect. A long-term follow-up].

Authors:  T Ach; G Kolling; K Rohrschneider; C Richter; D Haas; A Schmidt-Bacher
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

3.  Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.

Authors:  Erin A Boese; Nieraj Jain; Yali Jia; Catie L Schlechter; Cary O Harding; Simon S Gao; Rachel C Patel; David Huang; Richard G Weleber; Melanie B Gillingham; Mark E Pennesi
Journal:  Ophthalmology       Date:  2016-08-02       Impact factor: 12.079

4.  Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.

Authors:  C Bieneck Haglind; A Nordenström; S Ask; U von Döbeln; J Gustafsson; M Halldin Stenlid
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

Review 5.  Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.

Authors:  Ute Spiekerkoetter; Jean Bastin; Melanie Gillingham; Andrew Morris; Frits Wijburg; Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2010-09-10       Impact factor: 4.982

Review 6.  Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies.

Authors:  Autumn L Fletcher; Mark E Pennesi; Cary O Harding; Richard G Weleber; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2012-03-08       Impact factor: 4.797

7.  MULTIMODAL IMAGING AND ELECTRORETINOGRAPHY IN LONG-CHAIN 3-HYDROXYACYL COENZYME A DEHYDROGENASE DEFICIENCY.

Authors:  James Lin; Katherine Boudreault; Stephen Tsang
Journal:  Retin Cases Brief Rep       Date:  2017 Winter

8.  Diagnosis, Treatment, and Clinical Outcome of Patients with Mitochondrial Trifunctional Protein/Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency.

Authors:  Irene De Biase; Krista S Viau; Aiping Liu; Tatiana Yuzyuk; Lorenzo D Botto; Marzia Pasquali; Nicola Longo
Journal:  JIMD Rep       Date:  2016-04-28

9.  Neuropsychological Development in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency.

Authors:  A Strandqvist; C Bieneck Haglind; R H Zetterström; A Nemeth; U von Döbeln; M Halldin Stenlid; A Nordenström
Journal:  JIMD Rep       Date:  2015-11-07

Review 10.  Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.

Authors:  Sathish Kumar Natarajan; Jamal A Ibdah
Journal:  Int J Mol Sci       Date:  2018-01-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.